Adma Biologics reported $20.39M in Trade Debtors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Adma Biologics ADMA:US $ 20.39M 3.15M
Agile Therapeutics AGRX:US 1.31M 142K
Alnylam Pharmaceuticals ALNY:US $ 141.06M 505.52M
Biocryst Pharmaceuticals BCRX:US $ 26.21M 1.41M
Dynavax Technologies DVAX:US $ 200.36M 94.46M
Kindred Biosciences KIN:US 1.56M 11.16M
Novavax NVAX:US $ 109.96M 38.6M
Omeros OMER:US $ 33.9M 2.06M
Takeda 4502:JP Y 887295M 28338M